Bronchopulmonary Dysplasia (BPD)
Respiratory·MeSH: Bronchopulmonary Dysplasia
Prevalence
30.0 / 100K
2 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| surfactant | GH Research PLC (GHRS) |
Preclinical(1)
| Drug | Company |
|---|---|
| hcw11-040 | HCW Biologics Inc. (HCWB) |
Compare drugs
Frequently asked questions
How many drugs are in development for Bronchopulmonary Dysplasia (BPD)?
BioSniper tracks 2 drugs in development for Bronchopulmonary Dysplasia (BPD) across 2 companies.
How many clinical trials target Bronchopulmonary Dysplasia (BPD)?
There are 4 clinical trials targeting Bronchopulmonary Dysplasia (BPD) tracked by BioSniper.
What is the prevalence of Bronchopulmonary Dysplasia (BPD)?
The estimated prevalence of Bronchopulmonary Dysplasia (BPD) is approximately 30.0 per 100,000 population.
Deep-dive into Bronchopulmonary Dysplasia (BPD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis